At week @ , estimated mean ( @ % CI ) changes in LDL-C from baseline were -@ % ( -@ % to -@ % ) and -@ % ( -@ % to @ % ) for alirocumab and placebo , respectively , an estimated mean ( @ % CI ) difference of -@ % ( -@ % to -@ % ) ( P < @ ) .